Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06375083 · ClinicalTrials.gov registry record · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
A Phase 2 study of Depression and Suicide, sponsored by VA Eastern Colorado Health Care System.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 472
- Enrollment target
- 1
- Study location
NCT06375083: Recruiting Phase 2 study of Depression and Suicide, sponsored by VA Eastern Colorado Health Care System.
NCT06375083 is a Phase 2 study of Depression and Suicide that is actively recruiting participants, run by VA Eastern Colorado Health Care System. The registered enrollment target is 472 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06375083, a Phase 2 study of Depression and Suicide, is actively recruiting participants, sponsored by VA Eastern Colorado Health Care System.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 472 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about the use of one of two self-guided online cognitive behavioral therapy courses. One is focused on symptoms of depression and one is focused on history of suicidal thoughts and behaviors.
Primary Outcome
Acceptability
Conditions Studied
Interventions
- BEHAVIORAL c-CBT for Suicide Prevention
- BEHAVIORAL c-CBT or Depression
Study Locations (1)
Colorado
- Eastern Colorado Health Care System - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2026-08-30 |
| Phase | Phase 2 |
What NCT06375083 shows while recruiting
NCT06375083 is an interventional study that assigns participants to a tested intervention. The registered 472 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (40% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which c-CBT for Suicide Prevention is the first listed.
NCT06375083 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06375083 about?
NCT06375083 is a clinical study titled "Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression". This study plans to learn more about the use of one of two self-guided online cognitive behavioral therapy courses. One is focused on symptoms of depression and one is focused on history of suicidal thoughts and behaviors.
What is the current status of trial NCT06375083?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 472 participants. The study started on 2024-03-20. Estimated completion is 2026-08-30.
What conditions does trial NCT06375083 study?
This clinical trial studies the following conditions: Depression, Suicide.
What interventions are being tested in trial NCT06375083?
The interventions under investigation include: c-CBT for Suicide Prevention (BEHAVIORAL), c-CBT or Depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT06375083?
This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06375083 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06375083's enrollment target sits among peer trials
472 94th of 679 higher than 586 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
- NCT07199517 · 472 participants · NA
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
- NCT07225881 · 472 participants · NA
Eatwell Clinical Trial (R01)
- NCT03010150 · 471 participants
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy